In order to further promote the construction and development of tumor immunotherapy, deepen the learning of new knowledge and new progress in head and neck tumor radiotherapy, surgical treatment, immunotherapy, targeted therapy, etc., and further strengthen the clinical research level of oncologists, Chengdu High-tech Medical Association successfully held the "Head and Neck Cancer Surgery Immunology Forum" April 26, 2023.

The conference invited well-known experts in the field of head and neck cancer in western China to give lectures, focusing on topics such as standardized diagnosis and treatment of head and neck tumors, surgical strategies, and new progress in treatment, and all participating experts carried out motivational discussions according to the content of the conference.

This conference builds a platform for exchange and learning for experts and colleagues in the form of project reports, which is conducive to academic discussion and exchange of classic cases and cutting-edge technologies of head and neck cancer, and establishes the concept of comprehensive treatment and standardized treatment of immunology medicine. It is of great significance to promote high-quality clinical research and promote the level of clinical research in the field of head and neck cancer.